Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
01/08/1991 | US4983626 Anti-rheumatic agents and their use |
01/08/1991 | US4983605 Antitumor benzoylureas; nonionic surfactant as dispersant; cellulose, silicic anhydride, sucrose fatty acid ester and/or polyoxyethylene polyoxypropylene glycol as disintegrator |
01/08/1991 | US4983593 Vasodilators, hypotensive agents |
01/08/1991 | US4983583 Granulated compositions of polysaccharides, process for their preparation and use |
01/08/1991 | US4983401 Sustained release pharmaceutical preparations having pH controlled membrane coatings |
01/08/1991 | US4983399 Cellulose ester and lubricant |
01/08/1991 | US4983398 Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates |
01/08/1991 | US4983396 Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol |
01/08/1991 | US4983394 Flavor enhancing and medicinal taste masking agent |
01/08/1991 | US4983388 Process of preparing silicone composition, and cosmetic and lustering materials containing silicone composition obtained |
01/08/1991 | US4983386 Adding amino acids to aqueous acrylic polymer solution, controlling ph; radiation resistance |
01/08/1991 | US4983385 For wet body surface, water-soluble polymer hydrogel, methacrylate copolymer, solubilizer |
01/08/1991 | CA2062970A1 Benzophenanthridine alkaloids for topical acne treatment |
01/08/1991 | CA2035893A1 Stable preparation containing motilins |
01/08/1991 | CA2035892A1 Aqueous solution containing motilins |
01/08/1991 | CA2020654A1 Stabilized fgf composition and production thereof |
01/07/1991 | WO1991001004A1 Hybrid molecules |
01/07/1991 | CA2035868A1 Hybrid molecules |
01/06/1991 | CA2019086A1 Modified pf4 compositions and methods of use |
01/05/1991 | WO1991000280A1 6-(hydronaphtyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-ones and the corresponding hydroxy acids |
01/05/1991 | CA2060212A1 6-(hydronaphtyl-1-ethyl)-4-hydroxy-3,4,5,6-tetrahydro-2h- pyran-2-ones and the corresponding hydroxy acids |
01/02/1991 | EP0406015A1 Intermittent release dosage form |
01/02/1991 | EP0405930A2 Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives |
01/02/1991 | EP0405299A2 Composition for the treatment of acute herpetic neuralgia and post-herpetic neuralgia |
01/02/1991 | CN1048220A Polystyrenesulfonate |
01/02/1991 | CA1278521C Composition for personal care product comprising alkoxylated fatty alcohol and polysiloxane |
01/01/1991 | US4981979 Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
01/01/1991 | US4981953 Antitumor |
01/01/1991 | US4981902 Drug delivery |
01/01/1991 | US4981852 Hypotensive, diuretic, liquids |
01/01/1991 | US4981695 Composition comprising L-dopa |
01/01/1991 | US4981694 Penicillin preparation for rectal administration |
01/01/1991 | US4981693 Pharmaceutical composition for periodontal diseases |
01/01/1991 | US4981684 Formation of adjuvant complexes |
01/01/1991 | US4981681 Lotion mixture and method of treating psoriasis |
01/01/1991 | US4981678 Foamable biocide composition |
12/27/1990 | WO1990015807A1 Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties |
12/27/1990 | WO1990015628A1 Polymer/antibiotic conjugate |
12/27/1990 | WO1990015627A1 Methods and compositions for the preparation and use of site-directed immunologic reagents |
12/27/1990 | WO1990015614A1 ANTIGENIC EPITOPES PRESENT ON MEMBRANE-BOUND BUT NOT SECRETED IgA |
12/27/1990 | EP0404747A1 Novel polystyrenesulfonate |
12/27/1990 | EP0404640A1 5,6,7,8-Tetrahydro-1-naphtalenol derivatives, process for their preparation and their use as antioxidants in cosmetic and pharmaceutical compositions |
12/27/1990 | EP0404558A1 Liquid polymer composition, and method of use |
12/27/1990 | EP0404490A1 Fast dissolving dosage forms |
12/27/1990 | EP0404376A2 Buffered metronidazole compositions for intravaginal treatment of vaginal infections |
12/27/1990 | EP0403961A2 Magnetic protein conjugates, process to make them and their use |
12/27/1990 | EP0403959A1 Film forming aqueous coating preparation for solid pharmaceuticals, its production and use |
12/27/1990 | EP0403748A2 Oral lipid medicinal form |
12/27/1990 | EP0403605A1 Elastase inhibiting polymers and methods |
12/27/1990 | EP0348507A4 Pharmaceutical preparation for individual prophylaxis of venereal diseases and curing urogenital trichomoniasis |
12/27/1990 | EP0311632A4 Surface active lactams |
12/27/1990 | EP0229108B1 Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
12/27/1990 | EP0214995B1 Immunotoxin and method of making |
12/27/1990 | CA2019724A1 Stable, cosmetically acceptable topical gel formulation and method of treatment for acne |
12/25/1990 | US4980457 Coupling of ricin and antibody |
12/25/1990 | US4980378 Increase penetration of drugs |
12/25/1990 | US4980175 Liquid orally administrable compositions based on edible oils |
12/25/1990 | US4980171 Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative |
12/25/1990 | US4980169 Using capsicum oleoresin |
12/25/1990 | US4980165 Pharmaceutical formulations of plasminogen activator proteins |
12/21/1990 | WO1990015793A1 Novel polystyrenesulfonate |
12/21/1990 | WO1990015792A1 Novel cyclodextrin inclusion complexes |
12/21/1990 | CA2059282A1 Polystyrenesulfonate |
12/21/1990 | CA2058996A1 Cyclodextrin inclusion complexes |
12/20/1990 | CA2019228A1 Fast dissolving dosage forms |
12/19/1990 | EP0403400A1 Functionalized silicon oil-based aqueous dispersion cross-linking to an elastomer by elimination of water |
12/19/1990 | EP0403395A1 Process for the one-step preparation of cross-linked poly beta-alanine from acrylamide and a polyfunctional compound copolymerisable therewith |
12/19/1990 | EP0403383A1 Sustained release pharmaceutical formulations |
12/19/1990 | EP0403156A1 Improved monoclonal antibodies against the human alpha/beta t-cell receptor, their production and use |
12/19/1990 | EP0403048A2 Medicated compositions containing sucralfate and processes for their production |
12/19/1990 | EP0402933A2 Use of sucralfate humid gel as vehicle for drugs having topic activity and for cosmetics |
12/19/1990 | EP0402805A1 Lyophilized preparation of 6-(3-dimethylaminopropionyl)forskolin |
12/19/1990 | EP0402418A1 Physiological active liquid allergenic composition from biological raw materials |
12/19/1990 | EP0402369A1 Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
12/19/1990 | EP0211023B1 Pharmaceutical composition containing ubidecarenone |
12/19/1990 | CN1047803A Etoposide preparations |
12/19/1990 | CN1047802A Moisturing vehicle for topical application of vitamin a acid |
12/18/1990 | US4978772 Utilization of otilonium bromide (DCI) for topical application in the gastroinstestinal tract and related pharmaceutical formulation appropriate for such use |
12/18/1990 | US4978534 Viscosity controlling agent |
12/18/1990 | US4978532 Dosage form for administration of dehydroepiandrosterone |
12/18/1990 | US4978527 Aqueous mixture with iodine-containing copolymers forms hydrophobic wear resistant film on skin; drug delivery |
12/18/1990 | US4978516 Process for treating talc |
12/18/1990 | CA1277910C Color stabilized hydrogel dressing and process |
12/16/1990 | WO1990015596A1 Glucan drug delivery system and adjuvant |
12/16/1990 | CA2059275A1 Glucan drug delivery system and adjuvant |
12/16/1990 | CA2019108A1 Sustained release pharmaceutical formulations |
12/15/1990 | WO1990015619A1 FACTOR Xa BASED ANTICOAGULANT COMPOSITIONS |
12/15/1990 | CA2019012A1 Process for the preparation of cross-linked poly-.beta.-alanine in one step from acrylamide and a copolymerisable polyfunctional compound |
12/14/1990 | WO1991008734A1 Anhydrous oil-based liquid suspension for delivering a medicament |
12/14/1990 | CA2060501A1 Anhydrous oil-based liquid suspension for delivering a medicament |
12/14/1990 | CA2018945A1 Sucralfate and a medicament and methods for preparing same |
12/14/1990 | CA2018833A1 Polymer/antibiotic conjugate |
12/13/1990 | WO1990015141A2 Self-assembled, defective, non-self-propagating viral particles |
12/13/1990 | WO1990015077A1 Monoclonal antibody specific for bacterial transport proteins, and antibody-containing deodorant composition |
12/13/1990 | WO1990014881A2 Chelating agents for attaching metal ions to proteins |
12/13/1990 | WO1990014844A2 Sugars as cleavable linkers for the delivery and release of agents in native form |
12/13/1990 | WO1990014837A1 Adjuvant formulation comprising a submicron oil droplet emulsion |
12/13/1990 | WO1990014834A1 Pvp-hi-i2 complexes having a partition coefficient above 300, and process for making same |
12/13/1990 | WO1990014832A1 Improved intravaginal treatment of vaginal infections with buffered metronidazole compositions |
12/13/1990 | WO1990014819A1 An ointment |